Cover ImageSALE
市場調查報告書

拋棄式生物製程系統的全球市場:2017年∼2021年

Global Single-use Bioprocessing System Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 300227
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
拋棄式生物製程系統的全球市場:2017年∼2021年 Global Single-use Bioprocessing System Market 2017-2021
出版日期: 2017年04月26日 內容資訊: 英文 70 Pages
簡介

生物醫藥品的製造專門化的拋棄式生物製程設備及其配件所使用的生物製程技術急速發展。這些系統的目的,是降低鋼鐵製的生物反應器設備與其配件的殺菌、清洗、維護等相關的成本。全球拋棄式生物製程系統市場,預計從2017年到2021年的期間,以7.83%的年複合成長率擴大。

本報告提供拋棄式生物製程系統的全球市場調查,市場基本結構,及市場成長的主要影響因素,市場趨勢與市場規模的預測,各用途、產品類型、終端用戶、地區的詳細的趨勢,市場發展的方向性分析,競爭情形,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 調查範圍

第3章 調查手法

第4章 簡介

  • 市場概況

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各用途

  • 市場概要
  • 單株抗體(mAb)
  • 疫苗生產
  • 植物細胞培養
  • 末稍血管細胞移植(PSCT)
  • 其他

第7章 市場區隔:各產品類型

  • 市場概要
  • 袋子,攪拌機
  • 生物反應器,發酵槽
  • 過濾設備,取樣調查設備
  • 生物流程容器
  • 配管系統(連接器/管線)
  • 其他

第8章 市場區隔:終端用戶

  • 市場概要
  • 製藥企業
  • 受託臨床試驗實施機關(CTO),受託醫藥品製造機關(CMO)
  • 生物科技企業
  • 學術研究機關

第9章 地區區分

  • 市場概要
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 決策架構

第11章 推動市場要素與課題

  • 推動市場要素
  • 推動市場要素的影響力
  • 市場課題
  • 市場課題的影響力

第12章 市場趨勢

  • 下游拋棄式的登場
  • 促進生物製程系統的持續性發展的一次性使用科技(SUT)

第13章 供應商概要

  • 競爭模式

第14章 主要供應商分析

  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific
  • 其他主要供應商

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR12876

About Single-Use Bioprocessing System

The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products. Bioprocess is a technique that produces biological materials such as a genetically engineered microbial strain for commercial use. For example, commercially useful chemicals are produced through bioprocess techniques such as microbial fermentation or degradation. The traditional approaches in bioprocessing involve stainless steel equipment that are not just difficult to maintain but also time-consuming and costly.

Technavio's analysts forecast the global single-use bioprocessing system market to grow at a CAGR of 7.83% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global single-use bioprocessing system market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of key vendors to end-users such as pharmaceutical companies, CROs/CMOs, biotech companies, and academic and research institutions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Single-Use Bioprocessing System Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Broadley-James Corporation
  • Eppendorf
  • Saint-Gobain

Market driver

  • Single-use technology (SUT) combats global drug shortage problem.
  • For a full, detailed list, view our report

Market challenge

  • Risk of leachables and extractables from plastics used in disposable systems.
  • For a full, detailed list, view our report

Market trend

  • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stages.
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • mAB production
  • Vaccine production
  • Plant cell cultivation
  • PSCTs
  • Others

PART 07: Market segmentation by product type

  • Market overview
  • Bags and mixers
  • Bioreactors and fermenters
  • Filtration devices and sampling systems
  • Bioprocess containers
  • Tubing systems (connectors/pipes)
  • Others

PART 08: Market segmentation by end-users

  • Market overview
  • Pharmaceutical companies
  • CROs & CMOs
  • Biotechnology companies
  • Academic and research institutions

PART 09: Geographical segmentation

  • Market overview
  • Americas
  • EMEA
  • APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 12: Market trends

  • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stage
  • Emergence of downstream disposables
  • SUT aiding continuous bioprocessing

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Advantages of single-use technologies over stainless steel technology
  • Exhibit 02: Global single-use bioprocessing systems market ($ billions)
  • Exhibit 03: Ongoing trends in biopharmaceutical industry impacting the adoption of single-use technologies
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global single-use bioprocessing systems market by application 2016-2021 (%)
  • Exhibit 06: Global single-use bioprocessing systems market for mAB production 2016-2021 ($ millions)
  • Exhibit 07: Global single-use bioprocessing systems market for vaccine production 2016-2021 ($ millions)
  • Exhibit 08: Global single-use bioprocessing systems market for plant cell cultivation 2016-2021 ($ millions)
  • Exhibit 09: Global single-use bioprocessing systems market for PSCTs 2016-2021 ($ millions)
  • Exhibit 10: Global single-use bioprocessing systems market for other applications 2016-2021 ($ millions)
  • Exhibit 11: Global single-use bioprocessing systems market by product type 2016-2021 (%)
  • Exhibit 12: Global single-use bags and mixers market 2016-2021 ($ millions)
  • Exhibit 13: Global SUBs and fermenters market 2016-2021 ($ millions)
  • Exhibit 14: Global single-use filtration devices and sampling systems market 2016-2021 ($ millions)
  • Exhibit 15: Global single-use bioprocess containers market 2016-2021 ($ millions)
  • Exhibit 16: Global single-use tubing systems market 2016-2021 ($ millions)
  • Exhibit 17: Global single-use others market 2016-2021 ($ millions)
  • Exhibit 18: Global single-use bioprocessing systems market by end-users 2016 and 2021
  • Exhibit 19: Pharmaceutical companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
  • Exhibit 20: CROs and CMOs in global single-use bioprocessing systems market 2016-2021 ($ millions)
  • Exhibit 21: Biotech companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
  • Exhibit 22: Academic and research institutions in global single-use bioprocessing systems market 2016-2021 ($ millions)
  • Exhibit 23: Global single-use bioprocessing systems market by geography 2016-2021
  • Exhibit 24: Single-use bioprocessing systems market in Americas 2016-2021 ($ billions)
  • Exhibit 25: Single-use bioprocessing systems market in EMEA 2016-2021 ($ billions)
  • Exhibit 26: Single-use bioprocessing systems market in APAC 2016-2021 ($ billions)
  • Exhibit 27: Recent M&As in the single-use bioprocessing systems market
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Impact of challenges
  • Exhibit 30: Advantages of implementing single-use bioprocessing systems
  • Exhibit 31: Strategic success factor of consideration for companies
  • Exhibit 32: Danaher: Profile
  • Exhibit 33: Danaher: Strength analysis
  • Exhibit 34: Danaher: Strategy assessment
  • Exhibit 35: Danaher: Opportunity assessment
  • Exhibit 36: GE Healthcare: Profile
  • Exhibit 37: GE Healthcare: Strength analysis
  • Exhibit 38: GE Healthcare: Strategy assessment
  • Exhibit 39: GE Healthcare: Opportunity assessment
  • Exhibit 40: Merck: Profile
  • Exhibit 41: Merck: Strength analysis
  • Exhibit 42: Merck: Strategy assessment
  • Exhibit 43: Merck: Opportunity assessment
  • Exhibit 44: Sartorius: Profile
  • Exhibit 45: Sartorius: Strength analysis
  • Exhibit 46: Sartorius: Strategy assessment
  • Exhibit 47: Sartorius: Opportunity assessment
  • Exhibit 48: Thermo Fisher Scientific: Profile
  • Exhibit 49: Thermo Fisher Scientific: Strength analysis
  • Exhibit 50: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 51: Thermo Fisher Scientific: Opportunity assessment
Back to Top